Outcomes and readmissions in patients with nonalcoholic fatty liver disease undergoing catheter ablation for atrial fibrillation

Heart Rhythm. 2024 Apr;21(4):502-504. doi: 10.1016/j.hrthm.2023.12.019. Epub 2023 Dec 28.

Authors

Siddharth Agarwal¹, Muhammad Bilal Munir², Charu Debnath¹, Christopher V DeSimone³, Abhishek Deshmukh³, Stavros Stavrakis¹, Nandan S Anavekar³, Zain Ul Abideen Asad⁴

Affiliations

¹ Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
² Division of Cardiovascular Medicine, University of California, Davis, Sacramento, California.
³ Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
⁴ Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. Electronic address: zain-asad@ouhsc.edu.

PMID: 38159789
DOI: 10.1016/j.hrthm.2023.12.019

No abstract available

Keywords: Atrial fibrillation; Catheter ablation; Mortality; Nonalcoholic fatty liver disease; Outcomes.

MeSH terms

Atrial Fibrillation* / etiology
Atrial Fibrillation* / surgery
Catheter Ablation* / adverse effects
Humans
Non-alcoholic Fatty Liver Disease* / complications
Non-alcoholic Fatty Liver Disease* / surgery
Patient Readmission
Recurrence
Risk Factors
Treatment Outcome